Najlepsi lekarze wykonujący tomografię komputerową narządów miednicy mniejszej w Izraelu – TOP 6 lekarzy

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Lekarz specjalizuje się w diagnozowaniu różnych rodzajów nowotworów, w tym raka wątroby, płuc, prostaty, żołądka, nadnerczy, raka kory nadnerczy, raka piersi, przełyku oraz międzybłoniaka otrzewnej. Lekarz został wyróżniony licznymi nagrodami za wkład w edukację medyczną i badania, takimi jak Certyfikat Zasług za prezentacje badawcze i Magna Cum Lauda za pracę nad zakrzepicą żyły wrotnej u kandydatów do przeszczepu wątroby. Lekarz jest także członkiem kilku prestiżowych towarzystw, w tym Europejskiego Towarzystwa Radiologii Gastroenterologicznej i Brzusznej oraz Radiologicznego Towarzystwa Ameryki Północnej.<\/p>

Lekarz jest specjalistą w dziedzinie medycyny nuklearnej z 40-letnim doświadczeniem, koncentrującym się na obrazowaniu hybrydowym, obrazowaniu onkologicznym i molekularnym obrazowaniu piersi. Lekarz pracuje w Centrum Medycznym Sourasky i ma specjalizację w medycynie nuklearnej z Centrum Medycznego Rambam.<\/p>

Lekarz posiada tytuł MD z Wydziału Medycyny Sacklera, Uniwersytet Tel Awiwu, oraz tytuł PhD z Technionu - Izraelskiego Instytutu Technologii, z dodatkowymi studiami ukończonymi na Uniwersytecie Dalhousie, Kanada.<\/p>

Prof. Roy Mashiach, MD, is the Director of Gynecology at Sheba Medical Center. He is a leading expert in minimally invasive gynecologic surgery with over 30 years of experience. He focuses on laparoscopic and hysteroscopic hysterectomy. He also performs myoma removal, treats endometriosis, and offers fertility‑preserving procedures.

Recognition and roles: Named to Forbes Israel’s Best Doctors. Recipient of the Daniel F. Kott Award (AAGL). Chairman of the Israeli Society of Gynecological Endoscopy. Director of the Gynecologic Simulation Unit (M.S.R.). Clinical Associate Professor at Tel Aviv University. Training: MD from Tel Aviv University. Specialization at Lis Maternity & Women’s Hospital. Fellowship in Advanced Endoscopy at Université d’Auvergne.

Dr. Boaz Liberman, MD, is an orthopedic oncologist and sarcoma surgeon for adults and children. He directs the Orthopedic Oncology Unit and serves as Vice Head of Orthopedic Surgery at Sheba Medical Center. His focus is limb-sparing cancer surgery with functional reconstruction. He performs complex joint reconstruction, revision arthroplasty, MRgFUS, and reconstruction after bone metastases.

Education and training: MD, Tel Aviv University. Orthopedic surgery residency, Sheba Medical Center. Fellowships in Adult Reconstruction at Mount Sinai Hospital, Toronto, and in Orthopedic Oncology at Mount Sinai Hospital and Princess Margaret Cancer Centre. He is board-certified in Orthopedic Surgery and in Orthopedic Oncology Surgery. He is a Clinical Instructor at Tel Aviv University. Memberships include the Israel Medical Association, Israel Orthopedic Association, AATB, and EATB. He also serves on national advisory committees. His research covers bone and soft tissue sarcomas, serum markers, imaging-guided therapies, MRI arthrography, and the biomechanics of bone treated with MRgFUS.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.